In one paragraphArticle in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Almanelly Agabo-MartínezDepartamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México 04510, Mexico.
Erika Gomez-ChangDepartamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0000-0002-5506-1367 Erick Hernández-HipólitoDepartamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0009-0000-1146-6613 Elizabet Estrada-MuñizDepartamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Zacatenco, Ciudad de México 07360, Mexico.
Carolina Escobedo-MartínezDepartamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Campus Guanajuato, Guanajuato 36050, Mexico.ORCID 0000-0003-4932-2345 Marco A Obregón-MendozaInstituto de Química, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0000-0001-7932-2958 Raúl G EnríquezInstituto de Química, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0000-0002-2671-615X Libia VegaDepartamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Zacatenco, Ciudad de México 07360, Mexico.ORCID 0000-0002-4993-5267 Irma RomeroDepartamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0000-0002-2317-5466 Funding
Universidad Nacional Autónoma de México IN207622
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Anti-Bacterial AgentsCurcuminHelicobacter InfectionsHelicobacter pyloriProtective AgentsStomach UlcerAnimalsBiological AvailabilityDisease Models, AnimalEthanolMaleMetalsMiceMicrobial Sensitivity TestsTopoisomerase II InhibitorsToxicity Tests, SubacuteAnti-Bacterial AgentsCurcumindiacetylcurcuminEthanolMetalsProtective AgentsTopoisomerase II InhibitorsUreasediacetylcurcumin complexesgastroprotectionHelicobacter pyloriMICsubacute toxicityurease
Identifiers
PMID41097273
PMCPMC12525688
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390